SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-21-000120
Filing Date
2021-02-04
Accepted
2021-02-03 18:27:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G s13g_123120-foghorn.htm SC 13G 67476
  Complete submission text file 0000904454-21-000120.txt   68914
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Subject) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91795 | Film No.: 21587832
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 171627 BOSTON MA 02117
Business Address P.O. BOX 171627 BOSTON MA 02117 617-236-7909
Klarman Family Foundation (Filed by) CIK: 0001843177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MA
Type: SC 13G